Review

srf rabbit antiserum (Santa Cruz Biotechnology)

Santa Cruz Biotechnology is a verified supplier

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Santa Cruz Biotechnology srf rabbit antiserum

FIG. 1. <t>SRF</t> protein levels do not change with cellular age. (A) Western blots used equal amounts of protein from young (Y, 36 mean population doublings) and old (O, 82 mean population doublings) Hs68 ﬁbroblasts. Total (Tot) and nuclear (Nuc) extracts and <t>a</t> <t>polyclonal</t> antibody generated against full-length SRF were used. The arrow identiﬁes a 67-kDa band characteristic of native SRF. (B) Young and senescent primary human diploid ﬁbroblasts were ﬁxed and stained with rabbit anti-SRF followed by goat anti-rabbit antibody–Texas Red and counterstained with DAPI to visualize DNA.

Srf Rabbit Antiserum, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 294 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+srf+antiserum/Rabbit+anti-biotin+linker/10__1128_slash_mcb__24__16__7298___7311__2004-75-15-8
Average 94 stars, based on 294 article reviews

srf rabbit antiserum - by Bioz Stars, 2026-10

94/100 stars

Images

1) Product Images from "Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor"

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

Journal: Molecular and Cellular Biology

doi: 10.1128/mcb.24.16.7298-7311.2004

FIG. 1. SRF protein levels do not change with cellular age. (A) Western blots used equal amounts of protein from young (Y, 36 mean population doublings) and old (O, 82 mean population doublings) Hs68 ﬁbroblasts. Total (Tot) and nuclear (Nuc) extracts and a polyclonal antibody generated against full-length SRF were used. The arrow identiﬁes a 67-kDa band characteristic of native SRF. (B) Young and senescent primary human diploid ﬁbroblasts were ﬁxed and stained with rabbit anti-SRF followed by goat anti-rabbit antibody–Texas Red and counterstained with DAPI to visualize DNA.

Figure Legend Snippet: FIG. 1. SRF protein levels do not change with cellular age. (A) Western blots used equal amounts of protein from young (Y, 36 mean population doublings) and old (O, 82 mean population doublings) Hs68 ﬁbroblasts. Total (Tot) and nuclear (Nuc) extracts and a polyclonal antibody generated against full-length SRF were used. The arrow identiﬁes a 67-kDa band characteristic of native SRF. (B) Young and senescent primary human diploid ﬁbroblasts were ﬁxed and stained with rabbit anti-SRF followed by goat anti-rabbit antibody–Texas Red and counterstained with DAPI to visualize DNA.

Techniques Used: Western Blot, Generated, Staining

FIG. 2. Kinase activity in senescent-cell nuclear extracts inhibits SRF DNA binding activity. (A) EMSAs with 32P-labeled SRE oligonucleotide and SRF(His)6 previously incubated with nuclear extracts from young (Y) or old (O) nuclear extracts are shown in lanes 1 and 2. Parallel kinase reactions were incubated with mutant (mut) SRE (lanes 3 and 4), competed with a 100-fold excess of unlabeled wild-type (WT) SRE (lanes 5 and 6), or incubated with a 100-fold excess of unlabeled mutant SRE (lanes 7 and 8). Preincubation with polyclonal SRF antibody (SRF, lanes 9 and 10) supershifted or eliminated the SRF complex. Parallel reactions without SRF(His)6 did not form complexes. (B) SRF(His)6 was used in kinase reactions with equal amounts of young (Y), senescent (O), or a combination of young- and old-cell nuclear extracts (Y/O) and used in SRE EMSAs (lanes 2 to 4). A control (C) kinase reaction with SRF but without nuclear extract is shown in lane 1. Parallel reactions were also done in the presence of the phosphatase inhibitors sodium ﬂuoride (NaF) and sodium vanadate (Na-Van) (lanes 5 to 7). The proportional addition of senescent (Old%) nuclear extracts to young nuclear extracts (Young%) were also used in SRE EMSAs (lanes 8 to 12). (C) Reactions with SRF(His)6 incubated with kinases supplied from equal amounts of young (Y), senescent (O), or a combinations of young and old nuclear extracts (Y/O) with 10 M ATP were used in SRE EMSAs (lanes 2 to 4). A control (C) reaction with SRF but without nuclear extract is shown in lane 1. Parallel reactions were also carried out in the absence of ATP used in EMSAs (lanes 5 to 8). (D) Data were obtained from SRE EMSAs utilizing SRF kinase reactions in the presence of SRF(His)6 as the substrate and kinases supplied from equal amounts of young (Y) and senescent (O) nuclear extracts. Various amounts of the PKC inhibitors bisinodolylmaleimide II (Bis II; 25, 50, and 100 nM), chelerythrine chloride (CH-Cl; 1.25, 2.5 and 5 M), rottlerin (Rot; 5, 10, and 20 M), or dimethyl sulfoxide (DMSO, 1%) vehicle were used in each reaction. Control reactions with SRF but in the absence of nuclear extracts were also followed by EMSA and used to normalize experiments. Histograms show data from scanning densitometry of three independent EMSAs with the average ratio of young and old intensities relative to the control reaction under each drug concentration, with standard deviations shown by error bars.

Figure Legend Snippet: FIG. 2. Kinase activity in senescent-cell nuclear extracts inhibits SRF DNA binding activity. (A) EMSAs with 32P-labeled SRE oligonucleotide and SRF(His)6 previously incubated with nuclear extracts from young (Y) or old (O) nuclear extracts are shown in lanes 1 and 2. Parallel kinase reactions were incubated with mutant (mut) SRE (lanes 3 and 4), competed with a 100-fold excess of unlabeled wild-type (WT) SRE (lanes 5 and 6), or incubated with a 100-fold excess of unlabeled mutant SRE (lanes 7 and 8). Preincubation with polyclonal SRF antibody (SRF, lanes 9 and 10) supershifted or eliminated the SRF complex. Parallel reactions without SRF(His)6 did not form complexes. (B) SRF(His)6 was used in kinase reactions with equal amounts of young (Y), senescent (O), or a combination of young- and old-cell nuclear extracts (Y/O) and used in SRE EMSAs (lanes 2 to 4). A control (C) kinase reaction with SRF but without nuclear extract is shown in lane 1. Parallel reactions were also done in the presence of the phosphatase inhibitors sodium ﬂuoride (NaF) and sodium vanadate (Na-Van) (lanes 5 to 7). The proportional addition of senescent (Old%) nuclear extracts to young nuclear extracts (Young%) were also used in SRE EMSAs (lanes 8 to 12). (C) Reactions with SRF(His)6 incubated with kinases supplied from equal amounts of young (Y), senescent (O), or a combinations of young and old nuclear extracts (Y/O) with 10 M ATP were used in SRE EMSAs (lanes 2 to 4). A control (C) reaction with SRF but without nuclear extract is shown in lane 1. Parallel reactions were also carried out in the absence of ATP used in EMSAs (lanes 5 to 8). (D) Data were obtained from SRE EMSAs utilizing SRF kinase reactions in the presence of SRF(His)6 as the substrate and kinases supplied from equal amounts of young (Y) and senescent (O) nuclear extracts. Various amounts of the PKC inhibitors bisinodolylmaleimide II (Bis II; 25, 50, and 100 nM), chelerythrine chloride (CH-Cl; 1.25, 2.5 and 5 M), rottlerin (Rot; 5, 10, and 20 M), or dimethyl sulfoxide (DMSO, 1%) vehicle were used in each reaction. Control reactions with SRF but in the absence of nuclear extracts were also followed by EMSA and used to normalize experiments. Histograms show data from scanning densitometry of three independent EMSAs with the average ratio of young and old intensities relative to the control reaction under each drug concentration, with standard deviations shown by error bars.

Techniques Used: Activity Assay, Binding Assay, Labeling, Incubation, Mutagenesis, Control, Concentration Assay

FIG. 3. Speciﬁc PKC kinase inhibitors and activators modulate SRF DNA binding activity. (A) In vitro kinase reactions with SRF(His)6 and kinases supplied from equal amounts of young (Y), senescent (O), or a combination of young- and old-cell nuclear extracts (Y/O) were performed in the presence of [-32P]ATP. Control (C) reactions with SRF but without nuclear extract were also incubated in the presence of [-32P]ATP (lanes 1, 5, and 9). Parallel sets of reactions were carried out in the presence of either 20 M rottlerin (lanes 5 to 8) or 50 nM bistratene A (lanes 9 to 12), which inhibit and activate PKC, respectively (B). In vitro kinase reactions performed in parallel without radiolabel were used with labeled SRE EMSAs (lanes 13 to 24).

Figure Legend Snippet: FIG. 3. Speciﬁc PKC kinase inhibitors and activators modulate SRF DNA binding activity. (A) In vitro kinase reactions with SRF(His)6 and kinases supplied from equal amounts of young (Y), senescent (O), or a combination of young- and old-cell nuclear extracts (Y/O) were performed in the presence of [-32P]ATP. Control (C) reactions with SRF but without nuclear extract were also incubated in the presence of [-32P]ATP (lanes 1, 5, and 9). Parallel sets of reactions were carried out in the presence of either 20 M rottlerin (lanes 5 to 8) or 50 nM bistratene A (lanes 9 to 12), which inhibit and activate PKC, respectively (B). In vitro kinase reactions performed in parallel without radiolabel were used with labeled SRE EMSAs (lanes 13 to 24).

Techniques Used: Binding Assay, Activity Assay, In Vitro, Control, Incubation, Labeling

FIG. 5. PKC activity is elevated during senescence (A) Phospho- Thr-505 Western blot of total lysates of young (Y) and old (O) cells harvested after serum starvation for 48 h or when stimulated for 0.5 h with 100 nM phorbol myristate acetate. (B) The samples used in panel A were used in a PKC Western blot (sc-937) as a loading control for the phosphorylation-speciﬁc Western blot. (C) Lysates from young and old ﬁbroblasts were precipitated with anti-PKC antibody (sc-937), nonspeciﬁc rabbit immunoglobulin G, or beads. Kinase reactions were performed with aliquots of the immunoprecipitations described in panel B, [-32P]ATP, and SRF(His)6. (D) Precipitated PKC was vi- sualized by a Western blot with polyclonal goat anti-PKC (lanes 1 to 6). (E) Histogram of data obtained from scanning densitometry of three independent immunoprecipitation kinase reactions as described for panel C. Error bars indicate standard deviations.

Figure Legend Snippet: FIG. 5. PKC activity is elevated during senescence (A) Phospho- Thr-505 Western blot of total lysates of young (Y) and old (O) cells harvested after serum starvation for 48 h or when stimulated for 0.5 h with 100 nM phorbol myristate acetate. (B) The samples used in panel A were used in a PKC Western blot (sc-937) as a loading control for the phosphorylation-speciﬁc Western blot. (C) Lysates from young and old ﬁbroblasts were precipitated with anti-PKC antibody (sc-937), nonspeciﬁc rabbit immunoglobulin G, or beads. Kinase reactions were performed with aliquots of the immunoprecipitations described in panel B, [-32P]ATP, and SRF(His)6. (D) Precipitated PKC was vi- sualized by a Western blot with polyclonal goat anti-PKC (lanes 1 to 6). (E) Histogram of data obtained from scanning densitometry of three independent immunoprecipitation kinase reactions as described for panel C. Error bars indicate standard deviations.

Techniques Used: Activity Assay, Western Blot, Control, Phospho-proteomics, Immunoprecipitation

$FIG. 6. Recombinant PKC inhibits SRF DNA binding activity. (A) A preparative digest of PKC was performed by incubation for 3 h at 37°C with recombinant caspase 3. A PKC Western blot shows the liberation of the PKC catalytic fragment (PKC-CF). These preparative fractions were used in subsequent phosphorylation analyses with PKC. (C) Phosphorylation-speciﬁc Western blot and SRE EMSA of in vitro kinase assays with activated PKC (lanes 2 to 4), caspase-cleaved PKC (lanes 5 to 7), and recombinant casein kinase II (lanes 8 to 10). The kinases were used to phosphorylate SRF(His)6 in a time course of 45 to 180 min at 37°C. The control (lane 1) used SRF(His)6 alone under the same conditions without any kinase. Reaction products were used in SRE EMSAs (B) or in a Western blot with a phosphoserine/threonine-phenylalanine (Phe 1) antibody (C).$
Figure Legend Snippet: FIG. 6. Recombinant PKC inhibits SRF DNA binding activity. (A) A preparative digest of PKC was performed by incubation for 3 h at 37°C with recombinant caspase 3. A PKC Western blot shows the liberation of the PKC catalytic fragment (PKC-CF). These preparative fractions were used in subsequent phosphorylation analyses with PKC. (C) Phosphorylation-speciﬁc Western blot and SRE EMSA of in vitro kinase assays with activated PKC (lanes 2 to 4), caspase-cleaved PKC (lanes 5 to 7), and recombinant casein kinase II (lanes 8 to 10). The kinases were used to phosphorylate SRF(His)6 in a time course of 45 to 180 min at 37°C. The control (lane 1) used SRF(His)6 alone under the same conditions without any kinase. Reaction products were used in SRE EMSAs (B) or in a Western blot with a phosphoserine/threonine-phenylalanine (Phe 1) antibody (C).

Techniques Used: Recombinant, Binding Assay, Activity Assay, Incubation, Western Blot, Phospho-proteomics, In Vitro, Control

FIG. 7. PKC phosphorylates both native and recombinant SRF on T160, and mutation of this site blocks SRF inactivation. (A) The mutant form of SRF, A160, and wild-type SRF were subjected to PKC and casein kinase II treatment for 90 min. Kinase reactions with [-32P]ATP, SRF (wild type or A160), and PKC or casein kinase II were performed, and the results are shown in the top panel. Parallel reactions without radiolabel were analyzed by Western blotting with the Phe 1 or Arg 3 phosphorylation-speciﬁc antibodies and are shown in the bottom panels. (B) Parallel unlabeled reactions were also used in SRF-SRE EMSAs. Control (C) reactions in the EMSA used SRF T160 or A160 but were not treated with kinase. (C) Native SRF phospho-analysis was performed with young- and senescent-cell extracts treated with dimethyl sulfoxide (DMSO), rottlerin (Rot), or bistratene A (BisA) before harvesting. An immunoprecipitation with the SRF polyclonal was followed by resolution by SDS–10% PAGE and transfer. Western blots of native SRF used anti-SRF (SRF), phospho-S/T Phe 1 (anti-Phe 1), or phospho-S/T Arg 3 (anti-Arg-3) antibodies. (D) Small peptides of SRF which are generated by Glu-C digestion and contain the consensus sequence for the anti-phospho-Phe 1 antibody (S/T-F, boxed) or anti-phospho-Arg 3 antibody (RxxS/T, bold). (E) Peptide analysis was carried out by immunoprecipitating SRF from young (Y) and senescent (O) cell extracts after vehicle, bistratene A (BisA), or rottlerin (Rot) treatment, silver staining, isolation from gels, and digestion with Glu-C. The resulting peptides were resolved on a 15% Tricine gel and Western blotted with phospho-S/T Phe 1 (Phe 1) or phospho-S/T Arg 3 (Arg-3) antibodies.

Figure Legend Snippet: FIG. 7. PKC phosphorylates both native and recombinant SRF on T160, and mutation of this site blocks SRF inactivation. (A) The mutant form of SRF, A160, and wild-type SRF were subjected to PKC and casein kinase II treatment for 90 min. Kinase reactions with [-32P]ATP, SRF (wild type or A160), and PKC or casein kinase II were performed, and the results are shown in the top panel. Parallel reactions without radiolabel were analyzed by Western blotting with the Phe 1 or Arg 3 phosphorylation-speciﬁc antibodies and are shown in the bottom panels. (B) Parallel unlabeled reactions were also used in SRF-SRE EMSAs. Control (C) reactions in the EMSA used SRF T160 or A160 but were not treated with kinase. (C) Native SRF phospho-analysis was performed with young- and senescent-cell extracts treated with dimethyl sulfoxide (DMSO), rottlerin (Rot), or bistratene A (BisA) before harvesting. An immunoprecipitation with the SRF polyclonal was followed by resolution by SDS–10% PAGE and transfer. Western blots of native SRF used anti-SRF (SRF), phospho-S/T Phe 1 (anti-Phe 1), or phospho-S/T Arg 3 (anti-Arg-3) antibodies. (D) Small peptides of SRF which are generated by Glu-C digestion and contain the consensus sequence for the anti-phospho-Phe 1 antibody (S/T-F, boxed) or anti-phospho-Arg 3 antibody (RxxS/T, bold). (E) Peptide analysis was carried out by immunoprecipitating SRF from young (Y) and senescent (O) cell extracts after vehicle, bistratene A (BisA), or rottlerin (Rot) treatment, silver staining, isolation from gels, and digestion with Glu-C. The resulting peptides were resolved on a 15% Tricine gel and Western blotted with phospho-S/T Phe 1 (Phe 1) or phospho-S/T Arg 3 (Arg-3) antibodies.

Techniques Used: Recombinant, Mutagenesis, Western Blot, Phospho-proteomics, Control, Immunoprecipitation, Generated, Sequencing, Silver Staining, Isolation

FIG. 10. Rottlerin restores immediate-early gene expression in senescent ﬁbroblasts. (A) Young and senescent Hs68 cells were serum starved for 48 h prior to stimulation by serum for 60 to 105 min. All cells were treated for 4 h before harvest with 20 M rottlerin (lanes 11 to 20) or dimethyl sulfoxide vehicle (lanes 1 to 10). Total cellular extract was harvested and used in an Egr-1 Western blot. (B) Young (Y) and senescent (O) Hs68 ﬁbroblasts were serum starved for 48 h prior to stimulation by serum for 60 min. Cells were treated 4 h before harvest with 20 M rottlerin, 50 nM bistratene A, or dimethyl sulfoxide vehicle. Nuclear extracts from these cells were harvested and used in an SRF-SRE EMSA (C). RNA isolated from parallel plates of cells (described for B) and used as the substrate in RT-PCRS to detect c-fos transcript levels. Glyceralde- hhyde-3-phosphate dehydrogenase (GAPDH) served as an internal control for loading, ampliﬁcation, efﬁciency, and RNA integrity.

Figure Legend Snippet: FIG. 10. Rottlerin restores immediate-early gene expression in senescent ﬁbroblasts. (A) Young and senescent Hs68 cells were serum starved for 48 h prior to stimulation by serum for 60 to 105 min. All cells were treated for 4 h before harvest with 20 M rottlerin (lanes 11 to 20) or dimethyl sulfoxide vehicle (lanes 1 to 10). Total cellular extract was harvested and used in an Egr-1 Western blot. (B) Young (Y) and senescent (O) Hs68 ﬁbroblasts were serum starved for 48 h prior to stimulation by serum for 60 min. Cells were treated 4 h before harvest with 20 M rottlerin, 50 nM bistratene A, or dimethyl sulfoxide vehicle. Nuclear extracts from these cells were harvested and used in an SRF-SRE EMSA (C). RNA isolated from parallel plates of cells (described for B) and used as the substrate in RT-PCRS to detect c-fos transcript levels. Glyceralde- hhyde-3-phosphate dehydrogenase (GAPDH) served as an internal control for loading, ampliﬁcation, efﬁciency, and RNA integrity.

Techniques Used: Gene Expression, Western Blot, Isolation, Control

other:

Article Title: Basic Fibroblast Growth Factor Antagonizes Transforming Growth Factor-β1–Induced Smooth Muscle Gene Expression Through Extracellular Signal–Regulated Kinase 1/2 Signaling Pathway Activation
Article Snippet: SRF proteins were detected according to the ECL protocol (Amersham corp.) using 1: 1000 dilution of rabbit anti-SRF antiserum (Santa Cruz Biotechnology, Inc. 100 μg IgG/mL).

Image Search Results

Journal: Molecular and Cellular Biology

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

doi: 10.1128/mcb.24.16.7298-7311.2004

Figure Lengend Snippet: FIG. 1. SRF protein levels do not change with cellular age. (A) Western blots used equal amounts of protein from young (Y, 36 mean population doublings) and old (O, 82 mean population doublings) Hs68 ﬁbroblasts. Total (Tot) and nuclear (Nuc) extracts and a polyclonal antibody generated against full-length SRF were used. The arrow identiﬁes a 67-kDa band characteristic of native SRF. (B) Young and senescent primary human diploid ﬁbroblasts were ﬁxed and stained with rabbit anti-SRF followed by goat anti-rabbit antibody–Texas Red and counterstained with DAPI to visualize DNA.

Article Snippet: Incubation with 20 ng of PKC polyclonal antibody (Santa Cruz sc-937) or 0.5 l of SRF rabbit antiserum was carried out with 500 g of total cellular protein for 4 h at 4°C.

Techniques: Western Blot, Generated, Staining

Journal: Molecular and Cellular Biology

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

doi: 10.1128/mcb.24.16.7298-7311.2004

Figure Lengend Snippet: FIG. 2. Kinase activity in senescent-cell nuclear extracts inhibits SRF DNA binding activity. (A) EMSAs with 32P-labeled SRE oligonucleotide and SRF(His)6 previously incubated with nuclear extracts from young (Y) or old (O) nuclear extracts are shown in lanes 1 and 2. Parallel kinase reactions were incubated with mutant (mut) SRE (lanes 3 and 4), competed with a 100-fold excess of unlabeled wild-type (WT) SRE (lanes 5 and 6), or incubated with a 100-fold excess of unlabeled mutant SRE (lanes 7 and 8). Preincubation with polyclonal SRF antibody (SRF, lanes 9 and 10) supershifted or eliminated the SRF complex. Parallel reactions without SRF(His)6 did not form complexes. (B) SRF(His)6 was used in kinase reactions with equal amounts of young (Y), senescent (O), or a combination of young- and old-cell nuclear extracts (Y/O) and used in SRE EMSAs (lanes 2 to 4). A control (C) kinase reaction with SRF but without nuclear extract is shown in lane 1. Parallel reactions were also done in the presence of the phosphatase inhibitors sodium ﬂuoride (NaF) and sodium vanadate (Na-Van) (lanes 5 to 7). The proportional addition of senescent (Old%) nuclear extracts to young nuclear extracts (Young%) were also used in SRE EMSAs (lanes 8 to 12). (C) Reactions with SRF(His)6 incubated with kinases supplied from equal amounts of young (Y), senescent (O), or a combinations of young and old nuclear extracts (Y/O) with 10 M ATP were used in SRE EMSAs (lanes 2 to 4). A control (C) reaction with SRF but without nuclear extract is shown in lane 1. Parallel reactions were also carried out in the absence of ATP used in EMSAs (lanes 5 to 8). (D) Data were obtained from SRE EMSAs utilizing SRF kinase reactions in the presence of SRF(His)6 as the substrate and kinases supplied from equal amounts of young (Y) and senescent (O) nuclear extracts. Various amounts of the PKC inhibitors bisinodolylmaleimide II (Bis II; 25, 50, and 100 nM), chelerythrine chloride (CH-Cl; 1.25, 2.5 and 5 M), rottlerin (Rot; 5, 10, and 20 M), or dimethyl sulfoxide (DMSO, 1%) vehicle were used in each reaction. Control reactions with SRF but in the absence of nuclear extracts were also followed by EMSA and used to normalize experiments. Histograms show data from scanning densitometry of three independent EMSAs with the average ratio of young and old intensities relative to the control reaction under each drug concentration, with standard deviations shown by error bars.

Article Snippet: Incubation with 20 ng of PKC polyclonal antibody (Santa Cruz sc-937) or 0.5 l of SRF rabbit antiserum was carried out with 500 g of total cellular protein for 4 h at 4°C.

Techniques: Activity Assay, Binding Assay, Labeling, Incubation, Mutagenesis, Control, Concentration Assay

Journal: Molecular and Cellular Biology

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

doi: 10.1128/mcb.24.16.7298-7311.2004

Figure Lengend Snippet: FIG. 3. Speciﬁc PKC kinase inhibitors and activators modulate SRF DNA binding activity. (A) In vitro kinase reactions with SRF(His)6 and kinases supplied from equal amounts of young (Y), senescent (O), or a combination of young- and old-cell nuclear extracts (Y/O) were performed in the presence of [-32P]ATP. Control (C) reactions with SRF but without nuclear extract were also incubated in the presence of [-32P]ATP (lanes 1, 5, and 9). Parallel sets of reactions were carried out in the presence of either 20 M rottlerin (lanes 5 to 8) or 50 nM bistratene A (lanes 9 to 12), which inhibit and activate PKC, respectively (B). In vitro kinase reactions performed in parallel without radiolabel were used with labeled SRE EMSAs (lanes 13 to 24).

Article Snippet: Incubation with 20 ng of PKC polyclonal antibody (Santa Cruz sc-937) or 0.5 l of SRF rabbit antiserum was carried out with 500 g of total cellular protein for 4 h at 4°C.

Techniques: Binding Assay, Activity Assay, In Vitro, Control, Incubation, Labeling

Journal: Molecular and Cellular Biology

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

doi: 10.1128/mcb.24.16.7298-7311.2004

Figure Lengend Snippet: FIG. 5. PKC activity is elevated during senescence (A) Phospho- Thr-505 Western blot of total lysates of young (Y) and old (O) cells harvested after serum starvation for 48 h or when stimulated for 0.5 h with 100 nM phorbol myristate acetate. (B) The samples used in panel A were used in a PKC Western blot (sc-937) as a loading control for the phosphorylation-speciﬁc Western blot. (C) Lysates from young and old ﬁbroblasts were precipitated with anti-PKC antibody (sc-937), nonspeciﬁc rabbit immunoglobulin G, or beads. Kinase reactions were performed with aliquots of the immunoprecipitations described in panel B, [-32P]ATP, and SRF(His)6. (D) Precipitated PKC was vi- sualized by a Western blot with polyclonal goat anti-PKC (lanes 1 to 6). (E) Histogram of data obtained from scanning densitometry of three independent immunoprecipitation kinase reactions as described for panel C. Error bars indicate standard deviations.

Article Snippet: Incubation with 20 ng of PKC polyclonal antibody (Santa Cruz sc-937) or 0.5 l of SRF rabbit antiserum was carried out with 500 g of total cellular protein for 4 h at 4°C.

Techniques: Activity Assay, Western Blot, Control, Phospho-proteomics, Immunoprecipitation

Journal: Molecular and Cellular Biology

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

doi: 10.1128/mcb.24.16.7298-7311.2004

Figure Lengend Snippet: FIG. 6. Recombinant PKC inhibits SRF DNA binding activity. (A) A preparative digest of PKC was performed by incubation for 3 h at 37°C with recombinant caspase 3. A PKC Western blot shows the liberation of the PKC catalytic fragment (PKC-CF). These preparative fractions were used in subsequent phosphorylation analyses with PKC. (C) Phosphorylation-speciﬁc Western blot and SRE EMSA of in vitro kinase assays with activated PKC (lanes 2 to 4), caspase-cleaved PKC (lanes 5 to 7), and recombinant casein kinase II (lanes 8 to 10). The kinases were used to phosphorylate SRF(His)6 in a time course of 45 to 180 min at 37°C. The control (lane 1) used SRF(His)6 alone under the same conditions without any kinase. Reaction products were used in SRE EMSAs (B) or in a Western blot with a phosphoserine/threonine-phenylalanine (Phe 1) antibody (C).

Article Snippet: Incubation with 20 ng of PKC polyclonal antibody (Santa Cruz sc-937) or 0.5 l of SRF rabbit antiserum was carried out with 500 g of total cellular protein for 4 h at 4°C.

Techniques: Recombinant, Binding Assay, Activity Assay, Incubation, Western Blot, Phospho-proteomics, In Vitro, Control

Journal: Molecular and Cellular Biology

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

doi: 10.1128/mcb.24.16.7298-7311.2004

Figure Lengend Snippet: FIG. 7. PKC phosphorylates both native and recombinant SRF on T160, and mutation of this site blocks SRF inactivation. (A) The mutant form of SRF, A160, and wild-type SRF were subjected to PKC and casein kinase II treatment for 90 min. Kinase reactions with [-32P]ATP, SRF (wild type or A160), and PKC or casein kinase II were performed, and the results are shown in the top panel. Parallel reactions without radiolabel were analyzed by Western blotting with the Phe 1 or Arg 3 phosphorylation-speciﬁc antibodies and are shown in the bottom panels. (B) Parallel unlabeled reactions were also used in SRF-SRE EMSAs. Control (C) reactions in the EMSA used SRF T160 or A160 but were not treated with kinase. (C) Native SRF phospho-analysis was performed with young- and senescent-cell extracts treated with dimethyl sulfoxide (DMSO), rottlerin (Rot), or bistratene A (BisA) before harvesting. An immunoprecipitation with the SRF polyclonal was followed by resolution by SDS–10% PAGE and transfer. Western blots of native SRF used anti-SRF (SRF), phospho-S/T Phe 1 (anti-Phe 1), or phospho-S/T Arg 3 (anti-Arg-3) antibodies. (D) Small peptides of SRF which are generated by Glu-C digestion and contain the consensus sequence for the anti-phospho-Phe 1 antibody (S/T-F, boxed) or anti-phospho-Arg 3 antibody (RxxS/T, bold). (E) Peptide analysis was carried out by immunoprecipitating SRF from young (Y) and senescent (O) cell extracts after vehicle, bistratene A (BisA), or rottlerin (Rot) treatment, silver staining, isolation from gels, and digestion with Glu-C. The resulting peptides were resolved on a 15% Tricine gel and Western blotted with phospho-S/T Phe 1 (Phe 1) or phospho-S/T Arg 3 (Arg-3) antibodies.

Article Snippet: Incubation with 20 ng of PKC polyclonal antibody (Santa Cruz sc-937) or 0.5 l of SRF rabbit antiserum was carried out with 500 g of total cellular protein for 4 h at 4°C.

Techniques: Recombinant, Mutagenesis, Western Blot, Phospho-proteomics, Control, Immunoprecipitation, Generated, Sequencing, Silver Staining, Isolation

Journal: Molecular and Cellular Biology

Article Title: Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor

doi: 10.1128/mcb.24.16.7298-7311.2004

Figure Lengend Snippet: FIG. 10. Rottlerin restores immediate-early gene expression in senescent ﬁbroblasts. (A) Young and senescent Hs68 cells were serum starved for 48 h prior to stimulation by serum for 60 to 105 min. All cells were treated for 4 h before harvest with 20 M rottlerin (lanes 11 to 20) or dimethyl sulfoxide vehicle (lanes 1 to 10). Total cellular extract was harvested and used in an Egr-1 Western blot. (B) Young (Y) and senescent (O) Hs68 ﬁbroblasts were serum starved for 48 h prior to stimulation by serum for 60 min. Cells were treated 4 h before harvest with 20 M rottlerin, 50 nM bistratene A, or dimethyl sulfoxide vehicle. Nuclear extracts from these cells were harvested and used in an SRF-SRE EMSA (C). RNA isolated from parallel plates of cells (described for B) and used as the substrate in RT-PCRS to detect c-fos transcript levels. Glyceralde- hhyde-3-phosphate dehydrogenase (GAPDH) served as an internal control for loading, ampliﬁcation, efﬁciency, and RNA integrity.

Article Snippet: Incubation with 20 ng of PKC polyclonal antibody (Santa Cruz sc-937) or 0.5 l of SRF rabbit antiserum was carried out with 500 g of total cellular protein for 4 h at 4°C.

Techniques: Gene Expression, Western Blot, Isolation, Control

Review

srf rabbit antiserum (Santa Cruz Biotechnology)

Structured Review

Images

1) Product Images from "Protein Kinase Cδ Blocks Immediate-Early Gene Expression in Senescent Cells by Inactivating Serum Response Factor"

Related Articles

other:

Similar Products

Image Search Results